Donald Small

37.4k total citations · 12 hit papers
395 papers, 29.4k citations indexed

About

Donald Small is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Donald Small has authored 395 papers receiving a total of 29.4k indexed citations (citations by other indexed papers that have themselves been cited), including 159 papers in Molecular Biology, 134 papers in Hematology and 72 papers in Genetics. Recurrent topics in Donald Small's work include Acute Myeloid Leukemia Research (116 papers), Chronic Myeloid Leukemia Treatments (79 papers) and Chronic Lymphocytic Leukemia Research (58 papers). Donald Small is often cited by papers focused on Acute Myeloid Leukemia Research (116 papers), Chronic Myeloid Leukemia Treatments (79 papers) and Chronic Lymphocytic Leukemia Research (58 papers). Donald Small collaborates with scholars based in United States, France and Canada. Donald Small's co-authors include G. Graham Shipley, Martin C. Carey, Mark J. Levis, James A. Hamilton, Martin J. Janiak, Alan R. Tall, William H. Admirand, David Atkinson, David P. Cistola and Alan F. Hofmann and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Donald Small

390 papers receiving 27.4k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The physicochemical basis of cholesterol gallstone formation in man

1968 860 citations Donald Small et al. Journal of Clinical Investigation profile →
Nature of the thermal pretransition of synthetic phospholipids: dimyristoyl- and dipalmitoyllecithin

1976 849 citations Donald Small et al. Biochemistry profile →
The Physical Chemistry of Lipids

1986 815 citations Donald Small profile →
Lipid Digestion and Absorption

1983 672 citations Martin C. Carey, Donald Small et al. profile →
Temperature and compositional dependence of the structure of hydrated dimyristoyl lecithin.

1979 598 citations Donald Small et al. Journal of Biological Chemistry profile →
The physical chemistry of cholesterol solubility in bile. Relationship to gallstone formation and dissolution in man.

1978 589 citations Martin C. Carey, Donald Small Journal of Clinical Investigation profile →
Detergent Properties of Bile Salts: Correlation with Physiological Function

1967 532 citations Donald Small et al. profile →
Plasma High-Density Lipoproteins

1978 410 citations Donald Small et al. profile →
Phase equilibria and structure of dry and hydrated egg lecithin

1967 408 citations Donald Small profile →
Studies on simple and mixed bile salt micelles by nuclear magnetic resonance spectroscopy

1969 340 citations Donald Small et al. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism profile →
The characteristics of mixed micellar solutions with particular reference to bile

1970 333 citations Martin C. Carey, Donald Small profile →
Structure and interactions of lipids in human plasma low density lipoproteins.

1977 321 citations Donald Small et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Donald Small

Since Specialization

Citations

This map shows the geographic impact of Donald Small's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald Small with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald Small more than expected).

Fields of papers citing papers by Donald Small

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald Small. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald Small. The network helps show where Donald Small may publish in the future.

Co-authorship network of co-authors of Donald Small

This figure shows the co-authorship network connecting the top 25 collaborators of Donald Small. A scholar is included among the top collaborators of Donald Small based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald Small. Donald Small is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Targeting rapid TKI ‐induced AXL upregulation overcomes adaptive ERK reactivation and exerts antileukemic effects in FLT3 / ITD acute myeloid leukemia 2024 ·Molecular Oncology ·(unknown), Li Li, (unknown), Min‐Min Chou, (unknown), Jaesung Seo, (unknown), Mark J. Levis, Christine A. Pratilas, Donald Small	0
2	A Method for Overcoming Plasma Protein Inhibition of Tyrosine Kinase Inhibitors 2021 ·Blood Cancer Discovery ·David J. Young, Bao Nguyen, Li Li, Tomoyasu Higashimoto, Mark J. Levis, Jun O. Liu, Donald Small	7
3	Adaptation to TKI Treatment Reactivates ERK Signaling in Tyrosine Kinase–Driven Leukemias and Other Malignancies 2017 ·Cancer Research ·(unknown), S. Hayley, Li Li, Alice Can Ran Qin, Michelle A. Rudek, Richard J. Jones, Mark J. Levis, Keith W. Pratz, Christine A. Pratilas, Donald Small	32
4	FLT3 Kinase Inhibitor TTT-3002 Overcomes Both Activating and Drug Resistance Mutations in FLT3 in Acute Myeloid Leukemia 2014 ·Cancer Research ·S. Hayley, Bao Nguyen, Amy S. Duffield, Li Li, (unknown), (unknown), Patrick A. Brown, Mark J. Levis, Daniel J. Leahy, Donald Small	25
5	Signal Transduction Inhibition of APCs Diminishes Th17 and Th1 Responses in Experimental Autoimmune Encephalomyelitis 2009 ·The Journal of Immunology ·Mario Škarica, Tianhong Wang, (unknown), (unknown), Peter A. Calabresi, Donald Small, Katharine A. Whartenby	42
6	Internal tandem duplication of FLT3 induces increased ROS production, DNA damage and misrepair: implications for RAC1-STAT5 function in genomic instability in myeloid malignancies 2007 ·Cancer Research ·Kamal Datta, (unknown), (unknown), Paul Shapiro, Donald Small, Feyruz V. Rassool	1
7	Block of C/EBPα function by phosphorylation in acute myeloid leukemia with FLT3 activating mutations 2006 ·The Journal of Experimental Medicine ·Hanna S. Radomska, Daniela S. Daniela Sanchez Bassères, Rui Zheng, Pu Zhang, Tajhal Dayaram, Yukiya Yamamoto, David Sternberg, Nathalie A. Lokker, Neill A. Giese, Stefan K. Bohlander, Susanne Schnittger, Marie-Hélène Delmotte, Roger J. Davis, Donald Small, Wolfgang Hiddemann, D. Gary Gilliland, Daniel G. Tenen	161
8	Pharmacokinetic and Pharmacodynamic Studies of Lestaurtinib (CEP-701) and PKC-412: Cytotoxicity Is Often Dependent on Non-FLT3-Mediated Effects. 2005 ·Blood ·Mark J. Levis, Adam Stine, (unknown), Benjamin D. Smith, Judith E. Karp, Richard M. Stone, Elihu H. Estey, Frank Giles, Hagop M. Kantarjian, Pamela Cohen, Yanfeng Wang, Donald Small	11
9	The Interfacial Properties of ApoA-I and an Amphipathic -Helix Consensus Peptide of Exchangeable Apolipoproteins at the Triolein/Water Interface 2005 ·Journal of Biological Chemistry ·Lianjun Wang, David Atkinson, Donald Small	22
10	Novel FLT3 tyrosine kinase inhibitors 2003 ·Expert Opinion on Investigational Drugs ·Mark J. Levis, Donald Small	24
11	Inhibition of the transforming activity of FLT3 internal tandem duplication mutants from AML patients by a tyrosine kinase inhibitor 2002 ·Leukemia ·(unknown), Jan P. Allebach, Mark J. Levis, (unknown), F.D. Böhmer, Donald Small	82
12	SZF1 1999 ·Experimental Hematology ·(unknown), Mark E. Levenstein, (unknown), (unknown), (unknown), Constance A. Griffin, Curt I. Civin, Donald Small	16
13	Cryoelectron Microscopy of a Nucleating Model Bile in Vitreous Ice: Formation of Primordial Vesicles 1999 ·Biophysical Journal ·Donald Gantz, David Q.‐H. Wang, (unknown), Donald Small	33
14	Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays. 1997 ·The Journal of Rheumatology ·D P McCauliffe, (unknown), Minoru Satoh, Westley H. Reeves, Donald Small	29
15	Filamentous, helical, and tubular microstructures during cholesterol crystallization from bile. Evidence that cholesterol does not nucleate classic monohydrate plates. 1992 ·Journal of Clinical Investigation ·(unknown), Doo Soo Chung, J. Donovan, Donald Small, Martin C. Carey	129
16	The Lipid Surface of Triglyceride-Rich Particles Can Modulate (Apo)Protein Binding and Tissue Uptake 1990 ·Advances in experimental medicine and biology ·Donald Small, Susanne Bennett Clark, (unknown), (unknown), Donald Gantz, Arie Derksen	9
17	The partitioning of fatty acid and cholesterol between core and surfaces of phosphatidylcholine-triolein emulsions at pH 7.4 1988 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·(unknown), Arie Derksen, Donald Small	15
18	Secondary and Tertiary Structure of Apolipoproteins 1988 ·Advances in experimental medicine and biology ·Mary T. Walsh, James A. Hamilton, David Atkinson, Donald Small	1
19	Ionization and phase behavior of fatty acids in water: application of the Gibbs phase rule 1988 ·Biochemistry ·David P. Cistola, James A. Hamilton, David H. K. Jackson, Donald Small	391
20	The physical chemistry of lipids : from alkanes to phospholipids 1986 ·Plenum Press eBooks ·Donald Small	350

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact